As of May 27
| +0.76 / +5.46%|
The 7 analysts offering 12-month price forecasts for LeMaitre Vascular Inc have a median target of 18.50, with a high estimate of 21.00 and a low estimate of 17.00. The median estimate represents a +25.94% increase from the last price of 14.69.
The current consensus among 7 polled investment analysts is to Buy stock in LeMaitre Vascular Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.